496 related articles for article (PubMed ID: 33499003)
1. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.
Donlon NE; Power R; Hayes C; Davern M; Reynolds JV; Lysaght J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499003
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
3. Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond.
Lee YH; Tai D; Yip C; Choo SP; Chew V
Front Immunol; 2020; 11():568759. PubMed ID: 33117354
[TBL] [Abstract][Full Text] [Related]
4. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
5. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
Bader JE; Voss K; Rathmell JC
Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
[TBL] [Abstract][Full Text] [Related]
6. Targeting the immune milieu in gastrointestinal cancers.
Turkes F; Mencel J; Starling N
J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
[TBL] [Abstract][Full Text] [Related]
7. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies.
Zhang Y; Xu J; Zhang N; Chen M; Wang H; Zhu D
Cancer Lett; 2019 Aug; 458():123-135. PubMed ID: 31121212
[TBL] [Abstract][Full Text] [Related]
8. Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases.
He K; Barsoumian HB; Bertolet G; Verma V; Leuschner C; Koay EJ; Ludmir EB; Hsu E; Pisipati E; Voss TA; Puebla-Osorio N; Cortez MA; Welsh JW
Front Immunol; 2021; 12():812210. PubMed ID: 34975924
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
Vijayakumar G; Palese P; Goff PH
EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant immunotherapy in gastrointestinal cancers - The new standard of care?
Petricevic B; Kabiljo J; Zirnbauer R; Walczak H; Laengle J; Bergmann M
Semin Cancer Biol; 2022 Nov; 86(Pt 2):834-850. PubMed ID: 35671877
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
13. The complementarity of DDR, nucleic acids and anti-tumour immunity.
Kornepati AVR; Rogers CM; Sung P; Curiel TJ
Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
[TBL] [Abstract][Full Text] [Related]
14. Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses.
Liu N; Yang X; Gao C; Wang J; Zeng Y; Zhang L; Yin Q; Zhang T; Zhou H; Li K; Du J; Zhou S; Zhao X; Zhu H; Yang Z; Liu Z
J Nucl Med; 2024 May; 65(5):728-734. PubMed ID: 38514084
[TBL] [Abstract][Full Text] [Related]
15. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
16. Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review.
Mitrea DA; Froicu EM; Prenen H; Gambacorta MA; Span PN; Poortmans P
Crit Rev Oncol Hematol; 2024 Jul; 199():104381. PubMed ID: 38735504
[TBL] [Abstract][Full Text] [Related]
17. Immune targets in the tumor microenvironment treated by radiotherapy.
Ozpiskin OM; Zhang L; Li JJ
Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
[TBL] [Abstract][Full Text] [Related]
18. Immune effects of targeted radiation therapy for cancer.
Sridharan V; Schoenfeld JD
Discov Med; 2015 Mar; 19(104):219-28. PubMed ID: 25828526
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review.
Tagliaferri L; Lancellotta V; Fionda B; Mangoni M; Casà C; Di Stefani A; Pagliara MM; D'Aviero A; Schinzari G; Chiesa S; Mazzarella C; Manfrida S; Colloca GF; Marazzi F; Morganti AG; Blasi MA; Peris K; Tortora G; Valentini V
Hum Vaccin Immunother; 2022 May; 18(3):1903827. PubMed ID: 33847208
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
Zhou C; Zhang J
Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]